Navigation Links
World Glaucoma Day Set for March 6th
Date:1/30/2008

First Annual Observance To Draw Attention To 'The Sneak Thief of Sight'

NEW YORK, Jan. 30 /PRNewswire/ -- In an effort to combat one of the main causes of blindness around the globe, the World Glaucoma Association and the World Glaucoma Patient Organization have announced the first annual World Glaucoma Day, to be observed on March 6, 2008. The day will be marked by awareness and educational events organized by glaucoma institutions and local patient support groups worldwide, as listed on http://www.wgday.net. As well as striking the residents of developing countries at alarming rates, glaucoma is the second leading cause of blindness in the United States and the leading cause for African-Americans.

Known as "the sneak thief of sight," glaucoma is a disease characterized by gradual loss of vision resulting from death of the cells in the eye which transmits visual images through the optic nerve to the brain. As the optic nerve becomes increasingly damaged, permanent vision loss and blindness can occur. Early detection is the key to treating and halting the effects of glaucoma, but current worldwide estimates reveal that more than half of glaucoma sufferers do not even realize they have the disease.

"Because glaucoma strikes so silently and gradually, it is absolutely crucial to educate people about the value of early detection," said Robert Ritch, MD, professor and chief of glaucoma services at The New York Eye and Ear Infirmary, co-founder of the World Glaucoma Patient Association, and member of the World Glaucoma Day committee for the World Glaucoma Association. "For a disease that causes permanent blindness, it is truly unacceptable that so many people remain unaware of its impact and consequences. Individuals in our country need to be much more vigilant about glaucoma, especially if they fall into one of the higher risk groups."

Persons at high risk for glaucoma should have their eyes examined for the disease at least every two years by an eye care professional. In the United States, at risk groups include: people with a family history of glaucoma, African-Americans over the age of 40, people who are very nearsighted or farsighted, and all persons over the age of 60.

In the early stages of glaucoma, there may be no symptoms and vision can appear to be normal until a large amount has been lost. If undetected and untreated, glaucoma will gradually claim all peripheral vision and move on to cause total blindness. With early detection, glaucoma can be treated with eye drops to lower intraocular pressure. Other standard methods of treatment include laser and operative surgery. Treatment can usually halt the disease, but it cannot reverse the damage that has been done. Glaucoma can develop in one or both eyes.

About World Glaucoma Association:

The World Glaucoma Association is an independent professional global organization dedicated to the overall improvement of glaucoma science and care. Comprised of leading medical experts and institutions throughout the world, the group's overall goal is to optimize the quality of glaucoma research and treatment through increased communication and cooperation among international glaucoma societies, industries, and patient organizations.

About World Glaucoma Patient Association:

The World Glaucoma Patient Association is an umbrella organization which supports glaucoma associations and networks worldwide in their efforts to educate and support their members so that all people with glaucoma can understand and better manage their disease. The WGPA will facilitate the establishment of new glaucoma support groups and coordinate communication and cooperation between existing groups, in addition to promoting international awareness of glaucoma as a cause of preventable blindness.


'/>"/>
SOURCE World Glaucoma Day
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
2. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
3. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
4. Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in Worlds Largest Stent Registry
5. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
6. Stereotaxis Niobe System Used to Perform More Than 10,000 Procedures Worldwide
7. NexGenix Pharmaceuticals Enters into Exclusive World-wide License to Develop Novel Hsp90 Inhibitors
8. PATH, World Health Organization, and Partners Introduce Meningitis Vaccine in Burkina Faso
9. Doping technique brings nanomechanical devices into the semiconductor world
10. Advanced Instruments Introduces Worlds Fastest High Throughput Freezing Point Osmometer
11. Celebrities and Notables From the Worlds of Film, Television, Music and Sports Join Lifetime Televisions 13th Annual Multi-Platform Stop Breast Cancer For Life Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... ... 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers use ... 6000i models are higher end machines that use the more unconventional z-dimension of 20mm. ... from the bottom of the cuvette holder. , FireflySci has developed several Agilent ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... MA (PRWEB) , ... June 23, 2016 , ... ... Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute ... platform of microbial tests introduced last year,” stated Bob Salter, Vice President of ...
Breaking Biology Technology:
(Date:6/3/2016)... Das DOTM (Department ... hat ein 44 Millionen $-Projekt ... einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an Decatur ... Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale Anbieter ... aber Decatur wurde als konformste und innovativste ...
(Date:6/2/2016)... The Weather Company , an IBM Business (NYSE: IBM ... which consumers will be able to interact with IBM Watson ... or text and receive relevant information about the product or ... long sought an advertising solution that can create a one-to-one ... valuable; and can scale across millions of interactions and touchpoints. ...
(Date:6/1/2016)... 1, 2016 Favorable Government Initiatives ... and Criminal Identification to Boost Global Biometrics System Market ... TechSci Research report, " Global Biometrics Market By ... and Opportunities, 2011 - 2021", the global biometrics market ... on account of growing security concerns across various end ...
Breaking Biology News(10 mins):